title: Hypertransaminasemia and severe hepatic steatosis without inflammation. A case report.
abstract: Nonalcoholic fatty liver disease (NAFLD) is a medical condition that may progress to end-stage liver disease. The spectrum of NAFLD is wide and ranges from simple fat accumulation in hepatocytes (steatosis), to fat accumulation plus necroinflammatory activity with or without fibrosis (steatohepatitis). In addition, NAFLD is the most common cause of abnormal liver-test results among adults with a prevalence of 13%-23%. This case report is an example of a patient with asymptomatic hypertransaminasemia and severe hepatic steatosis without inflammation in which the diagnosis was made by liver biopsy.
authors.affiliation: Department of Biomedical Research, Medica Sur Clinic & Foundation, Mexico City, Mexico. nmendez@medicasur.org.mx
authors.forename: Nahum
authors.initials: N
authors.lastname: Méndez-Sánchez
authors.forename: Daniel
authors.initials: D
authors.lastname: Motola-Kuba
authors.forename: Jesús
authors.initials: J
authors.lastname: Bahena-Aponte
authors.forename: Norberto
authors.initials: N
authors.lastname: Chavez-Tapia
authors.forename: Raúl
authors.initials: R
authors.lastname: Pichardo-Bahena
authors.forename: Misael
authors.initials: M
authors.lastname: Uribe
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood*; D001706:Biopsy; D015992:Body Mass Index; D003937:Diagnosis, Differential; D005234:Fatty Liver / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008099:Liver / Q000473:pathology*; D008111:Liver Function Tests; D008279:Magnetic Resonance Imaging; D008297:Male; D012307:Risk Factors
chemical_list: D000410:Alanine Transaminase